Blackmores Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Blackmores Limited with three other
pharmaceutical manufacturers in Australasia:
Auscann Group Holdings Ltd
sales of 861,770.00 Australian Dollars [US$591,467.22 ]
(956,472.00 Australian Dollars [US$656,464.99 ]
(2.92 million Australian Dollars [US$2.00 million]
of which 82%
was HyperImmune Products).
Blackmores Limited reported sales of A$609.50 million (US$418.33 million)
June of 2019.
a very small
increase of 1.4%
versus 2018, when the company's sales were A$601.14 million.